Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.
O'Brien, Susan; Rizzieri, David A.; Vey, Norbert; Ravandi, Farhad; Krug, Utz O.; Sekeres, Mikkael A.; Dennis, Mike; Venditti, Adriano; Berry, Donald A.; Jacobsen, Tove Flem; Staudacher, Karin; Bergeland, Trygve; Giles, Francis J.; British Journal of Haematology, 2012, vol. 158, issue 5, p 581, ISSN 00071048. ISBN 13652141.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef